Literature DB >> 16112268

Hormonal influences on cancer progression and prognosis.

G V Sherbet1.   

Abstract

Cell differentiation, proliferation, apoptosis, and cell motility are induced and regulated by a host of growth factors, vitamins, and hormones. The mode of function of these modifiers of biological response, the signaling pathways that they activate, and the interacting pathways that can influence the biological outcome have been the focus of attention. Especially recognized and discussed in this review is the deregulation of their function, leading to abnormalities in cell proliferation, alteration of intercellular adhesive cohesion, remodeling of the extracellular matrix, and invasive behavior and metastatic deposition that are so characteristic of tumor development and progression, which strongly underscores the concept of molecular progression of cancer constructed on the basis of the relationship between genetic changes and the biological events associated with cancer progression. The molecular changes associated with hormone- and vitamin-driven responses and the deregulation of the expression and function of their target genes seem to correlate with specific biological events linked with cancer invasion and progression, and these findings could lead to the establishment of new markers of progression and to the development of new strategies for patient management. The scope of this work has been restricted by design and is dictated by the field of interest of the author's laboratory, but it is hoped that this field would be regarded adequately to reflect the wide genre of scientific interest in this field of human disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112268     DOI: 10.1016/S0083-6729(05)71006-2

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  5 in total

1.  Discovering biomarkers for hormone-dependent tumors: in silico study on signaling pathways implicated in cell cycle and cytoskeleton regulation.

Authors:  Klaudia Waszczykowska; Karolina Prażanowska; Żaneta Kałuzińska; Damian Kołat; Elżbieta Płuciennik
Journal:  Mol Genet Genomics       Date:  2022-05-09       Impact factor: 3.291

Review 2.  Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment.

Authors:  Rosamaria Lappano; Lauren A Todd; Mia Stanic; Qi Cai; Marcello Maggiolini; Francesco Marincola; Violena Pietrobon
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

3.  Clinical laboratory and imaging evidence for effectiveness of agarose-agarose macrobeads containing stem-like cells derived from a mouse renal adenocarcinoma cell population (RMBs) in treatment-resistant, advanced metastatic colorectal cancer: Evaluation of a biological-systems approach to cancer therapy (U.S. FDA IND-BB 10091; NCT 02046174, NCT 01053013).

Authors:  Barry H Smith; Lawrence S Gazda; Thomas J Fahey; Angelica Nazarian; Melissa A Laramore; Prithy Martis; Zoe P Andrada; Joanne Thomas; Tapan Parikh; Sudipta Sureshbabu; Nathaniel Berman; Allyson J Ocean; Richard D Hall; David J Wolf
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

4.  ESR1 and EGF genetic variation in relation to breast cancer risk and survival.

Authors:  Kristjana Einarsdóttir; Hatef Darabi; Yi Li; Yen Ling Low; Yu Qing Li; Carine Bonnard; Arvid Sjölander; Kamila Czene; Sara Wedrén; Edison T Liu; Per Hall; Keith Humphreys; Jianjun Liu
Journal:  Breast Cancer Res       Date:  2008-02-14       Impact factor: 6.466

5.  STAT3 Target Genes Relevant to Human Cancers.

Authors:  Richard L Carpenter; Hui-Wen Lo
Journal:  Cancers (Basel)       Date:  2014-04-16       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.